- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT02958657
Effect of Exercise on Platelet Reactivity After Myocardial Infarction
Effect of Exercise Training on the Autonomic Nervous System and Its Correlation With Platelet Aggregability in a Post-myocardial Infarction Population
Przegląd badań
Status
Interwencja / Leczenie
Szczegółowy opis
Introduction:
Platelet reactivity is closely involved in the pathophysiology of acute coronary syndromes (ACS). However, despite the development of newer and more effective antiplatelet drugs (among other therapeutic interventions), the risk of ischemic events recurrence after an episode of ACS is still high.
On the other hand, acute and strenuous exercise, a known trigger of ACS, when performed by untrained individuals, leads to sympathetic hyperactivity and increased platelet aggregability. Contrary to these findings, regular supervised exercise training leads to regulation of the autonomic system with consequent decrease in the incidence of ACS, as shown in previous studies. However, the relationship between regular supervised exercise training on platelet activity in patients post-AMI on dual antiplatelet therapy, has not been previously studied and is the main goal of the present project.
Objectives:
This project aims to evaluate, in recent post-AMI patients on dual antiplatelet therapy, the impact of regular exercise training on platelet aggregability, analyzed by VerifyNowP2Y12® test. Secondary exploratory analysis includes: 1) the influence of acute and strenuous exercise on platelet aggregability measured immediately after the two cardiopulmonary exercise testing (CPET) that patients will be submitted; 2) the correlation between the level of platelet aggregability and MSNA in trained and control groups; 3) the influence of exercise training on platelet aggregability measured by Multiplate® adenosine diphosphate (ADP) test and Multiplate® aspirin (ASPI) test; 4) the influence of exercise training on the mean platelet volume (MPV) and platelet count; 5) the influence of exercise training in other laboratorial parameters as lipids, blood glucose and inflammatory activity; 6) finally, the primary endpoint of the study will be evaluated in different prespecified subgroups such as diabetics, elderly, obese and patients with chronic kidney disease.
2.1. Primary endpoint of the study: Evaluate the influence of regular supervised exercise training for 3 months on platelet aggregability, analyzed by VerifyNowP2Y12® test, in patients with recent AMI utilizing dual antiplatelet therapy.
2.2. Main secondary analyses:
A. Evaluate platelet aggregability immediately after acute exercise before and after the exercise training period; for this propose, blood sample will be drawn immediately after the first and second cardiopulmonary exercise testings, in trained and control groups.
B. Correlate the platelet aggregability level, evaluated by VerifyNowP2Y12®, Multiplate-ADP®, Multiplate-ASPI®, with the level of MSNA.
2.3. Other exploratory analyses:
A. Evaluate the primary endpoint of the study utilizing Multiplate-ASPI® and Multiplate-ADP®;
B. Evaluate the MPV in trained and control groups, and its correlation with platelet aggregability;
C. Analyze, in trained and control groups, the following parameters:
Platelet count; LDL-cholesterol; HDL-cholesterol; Triglycerides; Lipid transference for HDL; Fasting glucose; Glycated hemoglobin; C-reactive protein (CRP) ultrasensitive; B-type natriuretic peptide (BNP); Troponin and Creatine Kinase MB-mass peak obtained during hospitalization; Genetic polymorphisms; Heart rate variability and spontaneous baroreflex control.
D. Analyze the primary endpoint within the following subgroups, taking into account the parameters obtained during hospitalization:
Sex (male / female); ST segment elevation myocardial infarction (STEMI) or non-STEMI; Basal heart rate (<70 or ≥ 70 bpm); History of arterial hypertension (presence or absence); LDL levels (<100 or ≥ 100 mg/dL); Age ≥65 years and <65 years; Body Mass Index <30 or ≥ 30 kg / m2; Creatinine clearance (MDRD) <60ml / min / m2 or ≥ 60 ml / min / m2; Current or not smoking; History of diabetes (present or absent); HbA1c <6.5 or ≥ 6.5%; GRACE risk score ≥140 and <140; Beta-blocker use.
- Methodology:
This is a prospective, randomized study. Patients with stable AMI admitted to a Coronary Care Unit, eligible to participate, will be randomized to a supervised exercise training program for three months at a rehabilitation unit or to a control group not formally trained. Patients who agree to participate will be included after the necessary explanations and the signature of the informed consent form.
3.a. Sample size calculation: To perform the sample calculation, previously published data wich showed platelet agreeability average of 32.9 ± 16 P2Y12 reactions units (PRU) in post-AMI patients on ticagrelor was utilizes. For an expected 35% decrease in platelet aggregability at trained group, and taking into account power of 80% and alpha index of 0.05, including 31 patients in each group is required. Admitting a percentage of losses of 40% given the difficulties inherent in the assessment of the sympathetic activity and adherence to the training program, the initial plan contemplates the inclusion of 90 patients in the study.
4. Study design: Prospective study in which eligible patients with uncomplicated AMI admitted to a Coronary Care Unit will be randomized to performing a exercise training program by three months or for an untrained control group, at a 1:1 or 1:2 rate, in order to adjust for more frequent early follow-up interruptions in exercise training group. All patients included after the necessary explanations and after signing the informed consent form. The patients will be submitted to the collection of material for laboratory evaluation including platelet aggregability tests, the assessment of a CPET in 01 and 04 months of the follow-up (end of treatment). The MSNA will be performed at the end of followup.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Nie dotyczy
Kontakty i lokalizacje
Lokalizacje studiów
-
-
SP
-
Sao Paulo, SP, Brazylia, 05403-900
- Heart Institute of University of Sao Paulo Medical School
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
- Hospitalization for spontaneous STEMI or non-STEMI in patients older than 18 years.
Exclusion Criteria:
- Any condition that contraindicate physical activity;
- Regular exercise training practitioners prior to the ischemic event;
- Planned revascularization in the following 4 months;
- Hospitalization for cardiovascular events in the previous 12 months;
- Ventricular dysfunction, defined as left ventricular ejection fraction (LVEF) <45% on echocardiography, evaluated by Simpson's method);f) Killip class III and IV;
- High risk of arrhythmia and/or second and third degree atrioventricular block;
- Diabetes mellitus requiring intravenous insulin therapy during hospitalization;
- Important chronic kidney disease, defined by creatinine clearance<30ml/min/m2 (estimated by MDRD formula);
- Oral anticoagulation;
- Use of NSAIDs and/or dipyridamole;
- Contraindication to dual antiplatelet therapy;
- Serum hemoglobin level <10 g/dL;
- Use of glycoprotein IIB/IIIA inhibitors in the last 48 hours;
- Terminal illness;
- Liver disease or coagulopathy;
- Refusal to engage in an exercise training program.
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
---|---|
Eksperymentalny: Exercise Training
Patients randomized to the training group will start the supervised regular training program 01 month after the myocardial infarction, and it will last for three months.
|
Supervised exercise training program that includes two workouts per week for three months at a rehabilitation unit.
Inne nazwy:
|
Brak interwencji: Control Group
Patients in the control group will receive general instructions regarding rehabilitation post-acute myocardial infarction and will be followed for four months after the myocardial infarction.
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Platelet aggregability by VerifyNow-P2Y12®
Ramy czasowe: Before the second CPET (04 months pot-AMI)
|
To measure in recent post-AMI patients on dual antiplatelet therapy the impact of 03 months of regular exercise training (starting 30 days after the AMI) on platelet aggregability, analyzed by VerifyNow-P2Y12® test.
|
Before the second CPET (04 months pot-AMI)
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
---|---|---|
Platelet aggregability by Multiplate-ADP®
Ramy czasowe: After the first CPET (01 month post-AMI)
|
To analyze the influence of acute and strenuous exercise on platelet aggregability analysed by Multiplate-ADP® immediately after the first CPET.
|
After the first CPET (01 month post-AMI)
|
Platelet aggregability by Multiplate-ASPI®
Ramy czasowe: After the first CPET (01 month post-AMI)
|
To analyze the influence of acute and strenuous exercise on platelet aggregability analysed by Multiplate-ASPI® immediately after the first CPET.
|
After the first CPET (01 month post-AMI)
|
Platelet aggregability by Multiplate-ADP®
Ramy czasowe: After the second CPET (04 months post-AMI)
|
To analyze the influence of strenuous exercise on platelet aggregability measured by MultiplateADP® immediately after the second CPET.
|
After the second CPET (04 months post-AMI)
|
Platelet aggregability by Multiplate-ASPI®
Ramy czasowe: After the second CPET (04 months post-AMI)
|
To analyze the influence of strenuous exercise on platelet aggregability measured by MultiplateASPI® immediately after the second CPET.
|
After the second CPET (04 months post-AMI)
|
Sympathetic activity by MSNA
Ramy czasowe: Before the second CPET (04 months post-AMI)
|
To analyze the influence of exercise training on MSNA, measured by microneurography directly from the peroneal nerve and expressed by postganglionic muscle sympathetic nerve recordings burst frequency (bursts per minute).
|
Before the second CPET (04 months post-AMI)
|
Współpracownicy i badacze
Współpracownicy
Śledczy
- Główny śledczy: Talia F Dalçóquio, MD, Heart Institute (InCor) University of Sao Paulo Medical School
Publikacje i pomocne linki
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Rzeczywisty)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Oszacować)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Słowa kluczowe
Dodatkowe istotne warunki MeSH
Inne numery identyfikacyjne badania
- 12163
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .
Badania kliniczne na Exercise Training
-
Università degli Studi di SassariZakończonyStwardnienie rozsiane | Zmęczenie | SłabośćWłochy
-
Queen's UniversityZakończonySkuteczność Podręcznika zdrowienia jako narzędzia psychoedukacyjnego ułatwiającego powrót do zdrowiaZaburzenia psychiczneKanada
-
Beirut Arab UniversityZakończony
-
University of MiamiUnited States Department of DefenseRejestracja na zaproszenie
-
The Hong Kong Polytechnic UniversityZakończonyBezsenność, podstawowyHongkong
-
Oregon Health and Science UniversityUnited States Department of Defense; Colorado State University; Portland State...ZakończonySpać | Zachowanie zdrowotne | Dobre samopoczucieStany Zjednoczone
-
Diakonhjemmet HospitalThe Dam Foundation; The Norwegian Council for Musculoskeletal HealthRekrutacyjny
-
Centro Universitário Augusto MottaZakończonyBól | Ból pleców | Bóle krzyża | Manifestacje nerwowo-mięśniowe | Objawy i symptomyBrazylia
-
Ludwig-Maximilians - University of MunichPosit Science CorporationNieznany
-
Riphah International UniversityZakończony